Kangtai Biotech: Record of Investor Relations Activities from September 3 to September 4, 2024
Kangtai Biotech: Announcement of Supervisory Board Resolutions
Kangtai Biotech: Special Report on the Deposit and Use of Funds Raised for the 2024 Semi-Annual Year
Kangtai Biotech: Announcement of Board Resolutions
Shenzhen Kangtai Biological Products: Announcement on the approval of drug clinical trial approval for quadrivalent influenza virus split vaccine (6-35 month population).
Shenzhen Kangtai Biological Products: Announcement regarding the cancellation of the raised funds account.
Shenzhen Kangtai Biological Products: Announcement of Resolutions of the 22nd Meeting of the 7th Board of Directors.
Shenzhen Kangtai Biological Products: Announcement of Resolutions of the 21st Meeting of the 7th Board of Directors
Shenzhen Kangtai Biological Products: Announcement of Resolutions of the 20th Meeting of the 7th Board of Directors
Shenzhen Kangtai Biological Products: May 7, 2024 Investor Relations Activity Record Form (2023 Online Results Briefing)
Shenzhen Kangtai Biological Products: Investor Relations Activity Schedule for April 28, 2024
Shenzhen Kangtai Biological Products: 2023 Social Responsibility Report and ESG (Environmental, Social and Corporate Governance) Report (English version)
Shenzhen Kangtai Biological Products: Investor Relations Management System (April 2024)
Shenzhen Kangtai Biological Products: Insider Information Insider Registration Management System (April 2024)
Shenzhen Kangtai Biological Products: Report on the work of the Board of Supervisors for the year 2023
Shenzhen Kangtai Biological Products: 2023 Independent Director Debriefing Report (Luo Zhiquan)
Shenzhen Kangtai Biological Products: 2023 Independent Director Debriefing Report (Hu Keping)
Shenzhen Kangtai Biological Products: Special report on the storage and use of funds raised in 2023
Shenzhen Kangtai Biological Products: CITIC Construction Investment Securities Co., Ltd. special inspection report on the storage and use of funds raised by Shenzhen Kangtai Biological Products Co., Ltd. in 2023
Shenzhen Kangtai Biological Products: 2023 Accounting Firm Performance Evaluation Report and Board Audit Committee's Supervisory Duties Report on Accounting Firms
No Data